Trial Profile
Investigating Aspirin and Ticagrelor for the prevention of tumour cell-induced platelet aggregation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2020
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Cancer metastases; Platelet dysfunction
- Focus Pharmacodynamics
- 03 Apr 2020 Status changed from recruiting to completed.
- 10 Dec 2015 Accrual to date is 2% according to United Kingdom Clinical Research Network record
- 20 Aug 2015 New trial record